China National Medicines Corporation Ltd. (SHA:600511)
China flag China · Delayed Price · Currency is CNY
30.32
+0.50 (1.68%)
Apr 1, 2025, 2:45 PM CST

SHA:600511 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Operating Revenue
50,59749,59245,43646,44240,336
Upgrade
Other Revenue
-103.9962.9526.2643.04
Upgrade
Revenue
50,59749,69645,49946,46940,379
Upgrade
Revenue Growth (YoY)
1.81%9.22%-2.09%15.08%-9.55%
Upgrade
Cost of Revenue
47,00245,70441,68142,84837,242
Upgrade
Gross Profit
3,5953,9923,8173,6213,136
Upgrade
Selling, General & Admin
1,2671,4301,3921,3551,404
Upgrade
Research & Development
73.7171.26755.7551.87
Upgrade
Other Operating Expenses
117.34109.6946.91120.86105.54
Upgrade
Operating Expenses
1,4581,6181,4981,5661,571
Upgrade
Operating Income
2,1382,3742,3192,0551,566
Upgrade
Interest Expense
--31.57-26.88-43.71-56.81
Upgrade
Interest & Investment Income
514.17525.32362.42354.09279.16
Upgrade
Currency Exchange Gain (Loss)
-0.55-1.652.711.57
Upgrade
Other Non Operating Income (Expenses)
21.4-10.47-43.29-182.24
Upgrade
EBT Excluding Unusual Items
2,6732,8582,6092,3501,792
Upgrade
Gain (Loss) on Sale of Investments
-18.210.82---
Upgrade
Gain (Loss) on Sale of Assets
-0.190.081.68-0.070.07
Upgrade
Asset Writedown
-1.07----
Upgrade
Other Unusual Items
-62.4476.995.08125.4
Upgrade
Pretax Income
2,6542,9312,6882,4451,917
Upgrade
Income Tax Expense
523.83596.42559.18516.3408.09
Upgrade
Earnings From Continuing Operations
2,1302,3342,1291,9291,509
Upgrade
Minority Interest in Earnings
-129.65-188.47-164.65-174.42-126.56
Upgrade
Net Income
2,0002,1461,9641,7541,383
Upgrade
Net Income to Common
2,0002,1461,9641,7541,383
Upgrade
Net Income Growth
-6.80%9.26%11.97%26.86%-13.79%
Upgrade
Shares Outstanding (Basic)
755754755755754
Upgrade
Shares Outstanding (Diluted)
755754755755754
Upgrade
Shares Change (YoY)
0.00%-0.00%-0.00%-0.98%
Upgrade
EPS (Basic)
2.652.842.602.321.83
Upgrade
EPS (Diluted)
2.652.842.602.321.83
Upgrade
EPS Growth
-6.80%9.27%11.97%26.86%-12.94%
Upgrade
Free Cash Flow
1,5282,5822,2651,8621,233
Upgrade
Free Cash Flow Per Share
2.033.423.002.471.63
Upgrade
Dividend Per Share
-0.8540.7820.7000.550
Upgrade
Dividend Growth
-9.21%11.71%27.27%-13.79%
Upgrade
Gross Margin
7.11%8.03%8.39%7.79%7.77%
Upgrade
Operating Margin
4.23%4.78%5.10%4.42%3.88%
Upgrade
Profit Margin
3.95%4.32%4.32%3.77%3.42%
Upgrade
Free Cash Flow Margin
3.02%5.20%4.98%4.01%3.05%
Upgrade
EBITDA
2,2562,4802,4232,1551,669
Upgrade
EBITDA Margin
4.46%4.99%5.32%4.64%4.13%
Upgrade
D&A For EBITDA
118.63106.15103.86100.1103.46
Upgrade
EBIT
2,1382,3742,3192,0551,566
Upgrade
EBIT Margin
4.23%4.78%5.10%4.42%3.88%
Upgrade
Effective Tax Rate
19.74%20.35%20.80%21.12%21.28%
Upgrade
Revenue as Reported
-49,69645,49946,46940,379
Upgrade
Advertising Expenses
-6.73.252.253.2
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.